MDL 1456: In Re: Pharmaceutical Industry Average Wholesale Price Litigation
LEAD CASE NUMBER 1:01cv12257
These actions involve common questions of fact concerning whether the pharmaceutical defendants engaged in fraudulent marketing, sales and/or billing schemes by unlawfully inflating the average wholesale price of their Medicare covered prescription drugs in order to increase the sales of these drugs to health care professionals and thereby boost the pharmaceutical companies' profits. These cases have been assigned to Judge Patti B Saris.
To view the docket entries, they can click here.
To view the Liason Counsel information, they can click here.
To view the Opinions, they can click here.